Cases 61 - 70 of 196
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. et al v. AUROBINDO PHARMA LTD. et al
as 2:2020cv14833
Plaintiff:
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. and NORTON (WATERFORD) LTD.
Defendant:
AUROBINDO PHARMA USA, INC., AUROBINDO PHARMA LTD. and AUROLIFE PHARMA LLC
Cause Of Action: 15 U.S.C. § 1126
Merck Sharp & Dohme Corp. v. Aurobindo Pharma, Ltd. et al
as 1:2020cv01099
Defendant:
Aurobindo Pharma, Ltd. and Aurobindo Pharma USA Inc.
Plaintiff:
Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
MERCK SHARP & DOHME CORP. v. AUROBINDO PHARMA USA INC. et al
as 3:2020cv10444
Defendant:
AUROBINDO PHARMA USA INC., AUROBINDO PHARMA LTD. and AUROMEDICS PHARMA LLC
Plaintiff:
MERCK SHARP & DOHME CORP.
Cause Of Action: 35 U.S.C. § 271
UCB, Inc. et al v. Annora Pharma Private Limited et al
as 1:2020cv00987
Defendant:
Aurobindo Pharma USA Inc., Lupin Ltd., Apotex Corp. and others
Plaintiff:
UCB Biopharma SRL and UCB, Inc.
Cause Of Action: 35 U.S.C. § 271
ACADIA Pharmaceuticals Inc. v. Aurobindo Pharma Limited et al
as 1:2020cv00985
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Limited
Plaintiff:
ACADIA Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Cephalon, Inc. v. Aurobindo Pharma, Ltd. et al
as 1:2020cv00962
Defendant:
Aurobindo Pharma USA, Inc., Aurobindo Pharma, Ltd. and Eugia Pharma Specialities Ltd.
Plaintiff:
Cephalon, Inc.
Cause Of Action: 35 U.S.C. § 271
Merck Sharp & Dohme Corp. v. Aurobindo Pharma Limited et al
as 1:2020cv00949
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Limited
Plaintiff:
Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
Teva Pharmaceuticals International GmbH et al v. Aurobindo Pharma, Ltd. et al
as 1:2020cv00632
Plaintiff:
Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. and Cephalon, Inc.
Defendant:
Aurobindo Pharma, Ltd., Aurobindo Pharma USA, Inc. and Eugia Pharma Specialities Ltd.
Cause Of Action: 35 U.S.C. § 271
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA, INC.
as 1:2020cv03102
Plaintiff:
JANSSEN RESEARCH AND DEVELOPMENT, LLC, JANSSEN PHARMACEUTICA NV, MITSUBISHI TANABE PHARMA CORPORATION and others
Defendant:
AUROBINDO PHARMA USA, INC.
Cause Of Action: 15 U.S.C. § 1126
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
